| 000 | 00968 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250512053824.0 | ||
| 264 | 0 | _c19861007 | |
| 008 | 198610s 0 0 eng d | ||
| 022 | _a0379-0363 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoth, H J | |
| 245 | 0 | 0 |
_aPharmacokinetics and biotransformation of pyrazolinones. _h[electronic resource] |
| 260 |
_bAgents and actions. Supplements _c1986 |
||
| 300 |
_a205-21 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAminopyrine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAnalgesics _xmetabolism |
| 650 | 0 | 4 |
_aAntipyrine _xanalogs & derivatives |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 |
_aDipyrone _xmetabolism |
| 650 | 0 | 4 |
_aGastric Mucosa _xmetabolism |
| 650 | 0 | 4 | _aIntestinal Absorption |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 |
_aPyrazoles _xmetabolism |
| 650 | 0 | 4 | _aSolubility |
| 773 | 0 |
_tAgents and actions. Supplements _gvol. 19 _gp. 205-21 |
|
| 999 |
_c3468908 _d3468908 |
||